Rosiglitazone and delayed onset of proliferative diabetic retinopathy Lucy Q. MD, Angie child, MD, PhD, M. Griffin, Judah Folkman, MD, Lloyd Paul Aiello, PhD Archives of Ophthalmology . 126[ 6] 793 to 799th Click here.
The first analysis of the data showed that 14 eyes in the rosiglitazone group and 24 eyes in the comparison group an early stage of the disease than non – proliferative diabetic retinopathy not yet developed. After one year more of these eyes had proliferative diabetic retinopathy progressed – 7.7 percent of the rosiglitazone group and 29.2 percent of the comparison group. Shen and his colleagues calculated a 59.5 percent relative risk reduction in of progressive from the non-proliferative to proliferative form of the disease in patients with rosiglitazone behandelt.2 percent of the rosiglitazone group, as compared to 47.
The results of this analysis show that by preventing angiogenesis , the drug rosiglitazone may potentially thwart the development of retinopathy and maintenance of visual acuity.find If we are able, how to successfully heal PCOS, will not just we were able alleviate a together form of infertility but we can be able to be able to the cardiovascular diseases in many women. And high Eighteen sexually mature female swine the animals are study, the animals are divided into two treatment groups, one set is includes nine Ossabaw pork feeding a standard swine nutrition Another group will present nine Ossabaw swine fed to an infinite fatty and high – sugar diet.
The research scientists will examine all aspects of PCOS – induced barrenness including hormones and metabolism, the egg viability and development and ovarian cycles.